This proposal is a request for partial financial support for a workshop on High Throughput Drug Screening in Muscular Dystrophy to be held in Washington DC . The meeting is proposed for 1.5 days, in the time window between April 8-22. This workshop will be attended by representatives from virtually all academic and pharmaceutical laboratories pursuing HTS for muscular dystrophy, as well as key presentations on newly emerging assays and screening technologies that have not yet been applied to muscular dystrophy. The growing interest in HTS applied to muscular dystrophy in both academic and pharmaceutical labs, and the lack of any previous meeting devoted to this topic, makes this proposed workshop highly timely. The workshop will be organized into four sessions: Session 1 will focus on assay development (e.g. utrophin up-regulation, membrane stabilization, protease inhibition). Session 2 will focus on drug screening facilities, methods and drug libraries. Session 3 will focus on animal model facilities available for pre-clinical studies of HTS hits. Session 4 will focus on review and approval of specific deliverables by the attendees. The workshop will be limited to 15 speakers and 10 stake holders, however we will provide Webex transmission of the conference, with option of limited remote questions. Deliverables include development of a web site with linked information on speakers and slide presentations used during the workshop. In addition, we will develop an internet accessible description of existing muscular dystrophy HTS assay descriptions and site of development and research on these, as well as HTS drug screening facilities with descriptions of compound libraries and method of access.